Clinical management of rising prostate-specific antigen after radical retropubic prostatectomy

J. Kellogg Parsons, Alan Wayne Partin

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Introduction Approximately 40% of men diagnosed with prostate cancer will undergo radical prostatectomy.1 Of these, 15% to 46% will manifest an isolated, asymptomatic rise in postoperative PSA within 15 years. This phenomenon is referred to as biochemical recurrence. Since an estimated 75,000 radical prostatectomies are performed annually in the US, biochemical recurrence after prostatectomy represents a healthcare issue of considerable magnitude, affecting several thousand men each year.2.

Original languageEnglish (US)
Title of host publicationTreatment Methods for Early and Advanced Prostate Cancer
PublisherCRC Press
Pages107-113
Number of pages7
ISBN (Electronic)9780203091432
ISBN (Print)0415458935, 9780415458931
StatePublished - Jan 1 2008

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Clinical management of rising prostate-specific antigen after radical retropubic prostatectomy'. Together they form a unique fingerprint.

Cite this